Estrogen-suppressed in vitro maturation: a novel approach to in vitro maturation.

  title={Estrogen-suppressed in vitro maturation: a novel approach to in vitro maturation.},
  author={W. Vitek and J. Witmyer and S. Carson and J. Robins},
  journal={Fertility and sterility},
  volume={99 7},
  • W. Vitek, J. Witmyer, +1 author J. Robins
  • Published 2013
  • Biology, Medicine
  • Fertility and sterility
  • OBJECTIVE To evaluate the laboratory and clinical outcomes of estrogen-suppressed in vitro maturation (ES-IVM), a novel IVM protocol that eliminates the need for FSH stimulation and cycle monitoring. DESIGN Case series. SETTING Academic infertility center. PATIENT(S) Eighteen infertile couples undergoing ES-IVM (n = 20). Eligible candidates included women ≤38 years old with either polycystic ovarian syndrome, antral follicle count ≥15, and/or history of ovarian hyperstimulation syndrome… CONTINUE READING
    21 Citations
    In Vitro Maturation and Its Role in Clinical Assisted Reproductive Technology
    • 30
    In vitro maturation of human oocytes: Its role in infertility treatment and new possibilities
    • 48
    • PDF
    IVM results are comparable and may have advantages over standard IVF
    • 35
    • Highly Influenced
    Clinical definition paper on in vitro maturation of human oocytes.
    • 39
    • PDF
    Association between mild stimulated IVF/M cycle and early embryo arrest in sub fertile women with/without PCOS
    The effect of ovarian puncture on the endocrine profile of PCOS patients who undergo IVM
    • 9
    • PDF
    Oocyte in vitro maturation: A sytematic review
    • 12
    • Highly Influenced
    • PDF


    In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience.
    • 148
    • PDF
    In vitro maturation: a five‐year experience
    • 31
    Natural cycle IVF and oocyte in-vitro maturation in polycystic ovary syndrome: a collaborative prospective study.
    • 32
    In vitro maturation of human oocytes for assisted reproduction.
    • 140
    Combination of FSH priming and hCG priming for in-vitro maturation of human oocytes.
    • 124
    • PDF
    A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles†
    • 81
    • PDF